Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
about
Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Combined treatment, based on l ...... g carcinoma growth inhibition.
@en
Combined treatment, based on l ...... g carcinoma growth inhibition.
@nl
type
label
Combined treatment, based on l ...... g carcinoma growth inhibition.
@en
Combined treatment, based on l ...... g carcinoma growth inhibition.
@nl
prefLabel
Combined treatment, based on l ...... g carcinoma growth inhibition.
@en
Combined treatment, based on l ...... g carcinoma growth inhibition.
@nl
P2093
P2860
P356
P1476
Combined treatment, based on l ...... g carcinoma growth inhibition.
@en
P2093
Alexander V Belyavsky
Ivan B Cheglakov
Lyudmila S Krassikova
Saida S Karshieva
P2860
P304
P356
10.1002/JGM.2894
P577
2016-07-27T00:00:00Z